Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Revenue (2020 - 2025)

Neuroone Medical Technologies' Revenue history spans 12 years, with the latest figure at $2.9 million for Q4 2025.

  • For Q4 2025, Revenue fell 11.65% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $8.7 million, up 51.6%, while the annual FY2025 figure was $9.1 million, 163.47% up from the prior year.
  • Revenue reached $2.9 million in Q4 2025 per NMTC's latest filing, up from $2.7 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.3 million in Q4 2024 to a low of $18240.0 in Q1 2021.
  • Average Revenue over 5 years is $883680.6, with a median of $548041.0 recorded in 2023.
  • Peak YoY movement for Revenue: soared 1865.45% in 2023, then tumbled 63.29% in 2024.
  • A 5-year view of Revenue shows it stood at $33748.0 in 2021, then skyrocketed by 239.51% to $114579.0 in 2022, then skyrocketed by 753.25% to $977649.0 in 2023, then skyrocketed by 234.9% to $3.3 million in 2024, then dropped by 11.65% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Revenue are $2.9 million (Q4 2025), $2.7 million (Q3 2025), and $1.7 million (Q2 2025).